Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune checkpoint inhibitor administration during pregnancy: a case series
A. Andrikopoulou, Anna-Maria Korakiti, Kleoniki Apostolidou, et al.
ESMO Open (2021) Vol. 6, Iss. 5, pp. 100262-100262
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Immune Checkpoint Inhibitor Use During Pregnancy and Outcomes in Pregnant Individuals and Newborns
Paul Gougis, Anne-Sophie Hamy, Floriane Jochum, et al.
JAMA Network Open (2024) Vol. 7, Iss. 4, pp. e245625-e245625
Open Access | Times Cited: 14
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancer
Ann W. Silk, Christopher A. Barker, Shailender Bhatia, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 7, pp. e004434-e004434
Open Access | Times Cited: 28
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of melanoma, version 3.0
Anna C. Pavlick, Charlotte E. Ariyan, Elizabeth I. Buchbinder, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 10, pp. e006947-e006947
Open Access | Times Cited: 21
ESMO Expert Consensus Statements on the management of breast cancer during pregnancy (PrBC)
Sibylle Loibl, Hatem A. Azim, Thomas Bachelot, et al.
Annals of Oncology (2023) Vol. 34, Iss. 10, pp. 849-866
Closed Access | Times Cited: 20
Role of immune cells in the establishment of implantation and maintenance of pregnancy and immunomodulatory therapies for patients with repeated implantation failure and recurrent pregnancy loss
Shigeru Saito
Reproductive Medicine and Biology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Dominant immune cells in pregnancy and pregnancy complications: T helper cells (TH1/TH2, TH17/Treg cells), NK cells, MDSCs, and the immune checkpoints
Mojgan Esparvarinha, Sahar Madadi, Lida Aslanian‐Kalkhoran, et al.
Cell Biology International (2022) Vol. 47, Iss. 3, pp. 507-519
Closed Access | Times Cited: 25
Cardiovascular Risk Profile of Nivolumab Anti-cancer Therapy
Zaheer Qureshi, Zaofashan Zaheer, Zoha Asghar, et al.
American Journal of Clinical Oncology (2025)
Closed Access
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer
Mary L. Disis, Sarah F. Adams, Jyoti Bajpai, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 6, pp. e006624-e006624
Open Access | Times Cited: 12
Position statement on the diagnosis and management of acute leukaemia and aggressive lymphomas in pregnancy
Georgia Mills, Antonia Shand, Debra Kennedy, et al.
The Lancet Haematology (2025) Vol. 12, Iss. 2, pp. e151-e162
Closed Access
Successful Pregnancy Outcome in a Patient Treated with Pembrolizumab and Exposed to Fluoro-Deoxyglucose (18F-FDG) PET/CT: Case Report and Review of Literature
Anna Lucia Mastricci, Felice Sorrentino, Elisa Giansiracusa, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 140-140
Open Access
Immune Checkpoint Inhibitors and Pregnancy: Analysis of the VigiBase® Spontaneous Reporting System
Roberta Noseda, Laura Müller, Francesca Bedussi, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 173-173
Open Access | Times Cited: 15
Immunochemotherapy for life-threatening haematological malignancies in pregnancy: a systematic review of the literature and cross-sectional analysis of clinical trial eligibility
Georgia Mills, Verity Chadwick, Catherine Tang, et al.
The Lancet Haematology (2023) Vol. 10, Iss. 6, pp. e458-e467
Closed Access | Times Cited: 8
Checkpoint inhibitor immunotherapy during pregnancy for relapsed–refractory Hodgkin lymphoma
Andrew M. Evens, Justin S. Brandt, Cody J. Peer, et al.
American Journal of Hematology (2022) Vol. 97, Iss. 6, pp. 833-838
Open Access | Times Cited: 13
Novel approaches to managing gestational trophoblastic tumors in the age of immunotherapy
Lindsay Hennah, Michael J. Seckl, Ehsan Ghorani
International Journal of Gynecological Cancer (2023) Vol. 33, Iss. 3, pp. 414-419
Closed Access | Times Cited: 7
Pregnancy and Tumour: The Parallels and Differences in Regulatory T Cells
Prerana Muralidhara, Vanshika Sood, Vishnu Vinayak Ashok, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12
Outcomes after treatment of breast cancer during pregnancy including taxanes and/or granulocyte colony-stimulating factor use: findings from a multi-institutional retrospective analysis
Tal Sella, Pedro Exman, Siyang Ren, et al.
Breast Cancer Research and Treatment (2022) Vol. 194, Iss. 3, pp. 597-606
Closed Access | Times Cited: 8
Stem Cell Origin of Cancer: Clinical Implications beyond Immunotherapy for Drug versus Therapy Development in Cancer Care
Shi‐Ming Tu, Anup Kumar Trikannad, Sruthi Vellanki, et al.
Cancers (2024) Vol. 16, Iss. 6, pp. 1151-1151
Open Access | Times Cited: 1
Pregnancy and delivery in an advanced cancer survivor with immune checkpoint inhibitor-induced type 1 diabetes: a case report
Keiji Sugai, Takashi Miwa, Junya Kojima, et al.
Endocrine (2024) Vol. 85, Iss. 2, pp. 593-597
Open Access | Times Cited: 1
Future Directions for Gestational Trophoblastic Disease
Ehsan Ghorani, Michael J. Seckl
Hematology/Oncology Clinics of North America (2024)
Closed Access | Times Cited: 1
Breast cancer during pregnancy—The oncologist's point of view
Alexios Matikas, Jonas Bergh
Acta Obstetricia Et Gynecologica Scandinavica (2023) Vol. 103, Iss. 4, pp. 775-778
Open Access | Times Cited: 2
Uncomplicated pregnancy and delivery under ongoing nivolumab therapy for metastatic melanoma
Thilo Gambichler, Laura Susok
Melanoma Research (2022) Vol. 32, Iss. 2, pp. 131-132
Closed Access | Times Cited: 3
Case report: Reproductive organ preservation and subsequent pregnancy for an infertility patient with lynch syndrome-associated synchronous endometrial cancer and colon cancer after treatment with a PD-1 checkpoint inhibitor
Di Cao, Yu Gao, Rongxin Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 3
Breast Cancer and Pregnancy: Challenges for Maternal and Newborn Successful Outcomes
Rodrigo Gonçalves, Thaís Perez Vazquez, Ângela Francisca Trinconi, et al.
(2024), pp. 285-309
Closed Access
Maternal Soluble Programmed Death Ligand-1 (sPD-L1) and T-regulatory Cells (Tregs) Alteration in Preeclampsia: A Cross-Sectional Study From Eastern India
Prakruti Dash, Saurav Nayak, Bharath Kumar Koppisetty
Cureus (2024)
Open Access
Natural Killer Cells in the Uterus
Norman Shreeve, Delphine Depierreux, Francesco Colucci
Springer eBooks (2024), pp. 1-27
Closed Access
Page 1 - Next Page

Scroll to top